磁共振成像在泌乳素瘤管理中的应用：证据回顾。
Magnetic resonance imaging in the management of prolactinomas; a review of the evidence.
机构信息
Departments of Medicine (Endocrinology) and Neurological Surgery, and Northwest Pituitary Center, Oregon Health & Science University, Mail Code CH8N, 3303 SW Bond Ave, Portland, OR, 97239, USA.
Endocrinology Division, Department of Medicine, Hospital Universitario "Dr. José E. González", Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, Mexico.
出版信息
Pituitary. 2020 Feb;23(1):16-26. doi: 10.1007/s11102-019-01001-6.
PURPOSE
This review aimed to evaluate data on the use of magnetic resonance imaging in the management of prolactinomas.
METHODS
Recent literature about prolactinoma behavior and magnetic resonance imaging in the management of prolactinomas is reviewed.
RESULTS
A review of evidence regarding prolactinoma pituitary MRI follow-up; techniques and sequences, recent data on possible gadolinium retention, the role and a review of T2-weighted images in the identification of prolactinomas and frequently encountered clinical scenarios, as well as MRI correlation with prolactin secretion, tumor growth and prediction of response to medical therapy are presented.
CONCLUSION
The underlying decision to perform serial imaging in prolactinoma patients should be individualized on a case-by-case basis. Future studies should focus on alternative imaging methods and/or contract agents.
目的
本综述旨在评估磁共振成像在催乳素瘤管理中的应用数据。
方法
对催乳素瘤行为和磁共振成像在催乳素瘤管理中的应用的最新文献进行了回顾。
结果
对证据进行了综述，包括催乳素瘤垂体 MRI 随访；技术和序列、关于钆保留的最新数据、在识别催乳素瘤和常见临床情况下的作用以及 T2 加权图像的作用，以及 MRI 与催乳素分泌、肿瘤生长和预测对药物治疗的反应的相关性。
结论
在催乳素瘤患者中进行系列成像的基本决策应根据具体情况个体化。未来的研究应集中在替代成像方法和/或契约代理上。
Zotero 插件